Gts Securities LLC Ardelyx, Inc. Transaction History
Gts Securities LLC
- $45.4 Billion
- Q3 2024
A detailed history of Gts Securities LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 55,500 shares of ARDX stock, worth $253,635. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,500
Previous 73,800
24.8%
Holding current value
$253,635
Previous $546,000
30.04%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ARDX
# of Institutions
220Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Janus Henderson Group PLC London, X021.5MShares$98.4 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$80.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$62.1 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$55.5 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$40.9 Million0.07% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $707M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...